A controlled trial of high-dose intravenous immune globulin infusions as treatment for dermatomyositis.
about
Treatment for inclusion body myositisImmunosuppressant and immunomodulatory treatment for dermatomyositis and polymyositisIntravenous immunoglobulin for myasthenia gravisImmunosuppressant and immunomodulatory treatment for dermatomyositis and polymyositisIntravenous immunoglobulin for myasthenia gravisIntravenous immunoglobulin in the treatment of primary trigeminal neuralgia refractory to carbamazepine: a study protocol [ISRCTN33042138]Idiopathic Inflammatory Myopathies: Clinical Approach and ManagementThe Production Processes and Biological Effects of Intravenous ImmunoglobulinIntravenous Immunoglobulins: Mode of Action and Indications in Autoimmune and Inflammatory DermatosesTreatment of inflammatory myopathy: emerging therapies and therapeutic targetsScanning for Therapeutic Targets within the Cytokine Network of Idiopathic Inflammatory MyopathiesDevelopments in the classification and treatment of the juvenile idiopathic inflammatory myopathiesIdiopathic inflammatory myopathiesRituximab in the treatment of inflammatory myopathies: a reviewCyclosporin A and intravenous immunoglobulin treatment in polymyositis/dermatomyositisImmunotherapies for Immune-Mediated Myopathies: A Current Perspective6th International Immunoglobulin Symposium: poster presentations.Indications for intravenous gammaglobulin therapy in inflammatory myopathies.The role of immunoglobulin therapy in allergic diseases.Intravenous immunoglobulin treatment in neurological diseasesReview article: a therapeutic update on dermatomyositis/polymyositis.Idiopathic inflammatory myopathies.Favorable outcome of juvenile dermatomyositis treated without systemic corticosteroids.High-dose intravenous immunoglobulin exerts its beneficial effect in patients with dermatomyositis by blocking endomysial deposition of activated complement fragments.Cutaneous dermatomyositis: an updated review of treatment options and internal associations.Therapeutic advances and future prospects in immune-mediated inflammatory myopathies.Recent advances in the management of adult myositis.Cutaneous dermatomyositis in the era of biologicals.Results and long-term followup of intravenous immunoglobulin infusions in chronic, refractory polymyositis: an open study with thirty-five adult patients.Treatment of Clinically Amyopathic Dermatomyositis in adults: A Systematic Review.Intravenous immunoglobulin in neurological disease: a specialist review.Immunotherapy of inflammatory myopathies: practical approach and future prospects.Effects of intravenous immunoglobulin therapy in Japanese patients with polymyositis and dermatomyositis resistant to corticosteroids: a randomized double-blind placebo-controlled trial.An overview of polymyositis and dermatomyositis.Indications for IVIG in rheumatic diseasesIVIG--mechanisms of action.Drugs in induction and treatment of idiopathic inflammatory myopathiesThe role of intravenous immunoglobulin preparations in the treatment of systemic sclerosisModulation of endothelial cell function by normal polyspecific human intravenous immunoglobulins: a possible mechanism of action in vascular diseasesSecond-line agents in myositis: 1-year factorial trial of additional immunosuppression in patients who have partially responded to steroids.
P2860
Q24186948-09CC0631-FC2C-4500-8C51-68DCA303C9B2Q24201580-E4745B1C-F8F9-4AE9-B162-C695B788AD76Q24202443-560D77CF-0CCC-4F35-9667-A6B662A0B6ECQ24240771-26F1FC95-9177-4321-900A-5719017643F3Q24242078-AD87D957-E44E-425C-A47B-D2A727ED015CQ24800818-7831CFB2-7076-4F3A-A8BF-04416661BB09Q26744705-C632D35B-B94B-4D20-BE08-33E5C30BB1D5Q26752540-263CDB24-CA48-4071-8CEE-EADBB992101CQ26765226-36B054AC-B904-4BCA-91F6-9D57FBBCA8ECQ26796546-7BD9F1C3-AC1C-4363-BCCB-9ED86B57170FQ26798209-771810A1-2F84-47AE-B392-ECE84728A0A8Q26863125-F7CBD629-815B-44A1-8249-CACBBAF4518FQ27025125-7E3F5BC7-6F2C-49C9-80C5-4AF9E80AAB44Q28077745-10704260-93D7-4124-85B9-4AE2CDE29BB3Q28344601-668B7E71-4B3D-49DE-A20E-374E3591F244Q30699742-1A38F002-086E-48A7-8C74-368AFBF28F7FQ33386923-E4FFB32A-C0E8-4308-BC73-ECF2365F4264Q33596409-349C4ED3-6A3C-450E-8B89-8E912A6D3B24Q33708505-DB95C85D-CF13-49BF-90E5-E547E7FDB225Q33735178-80377842-69CE-4739-8845-4D63A5225503Q33848574-25CD2E5D-3AE1-4B96-BAAD-217316C4A5CBQ33924451-8E29F4A0-87CD-4B57-B37A-C0F38BF7B1FAQ34124740-A3FED239-4859-4E41-9A26-7AB9DA67D285Q34155637-75C00478-15B5-4A05-8AD0-5ABAD4F1C0F3Q34349952-0DD90CE7-010E-4B76-B998-2DAD627A11FEQ34409105-E570E302-A24D-457A-AFE4-DA659BC0468AQ34481555-9A36C982-32C2-4116-8861-D54CCD29487AQ34501531-D4C528F1-3F9D-4F74-A4B5-37AA2E09465FQ34521023-5508475B-BC12-4339-8C72-AE9A8EB7E67FQ34526090-AA3955F0-72D3-4624-B3CC-F63B36378D11Q34574581-07EAC8E8-90F3-41B1-8E62-E0A70196FF7AQ34627294-0D5C8ED3-5E46-48EA-A2B8-148D8160CF64Q34632851-362574A6-0800-431E-BD62-080873106CFBQ34667765-5D8905F5-E9C4-4ACF-8359-282B79AD6372Q35102141-98CAC10D-3C8A-4206-A43D-550C99B29415Q35161081-FC899E3F-F1D4-439A-AAE0-12CEFCC6C57CQ35281940-6F24A0A0-558E-4945-9A46-6F8169789314Q35550847-DB9C7B1C-2595-4CFD-BDB5-EEF125250C2BQ35753525-91F0EEB5-0353-47A8-BEB9-5ACAEAA96F0DQ35767694-C0DA5230-597F-41BB-9BCA-BAA0BB8283D8
P2860
A controlled trial of high-dose intravenous immune globulin infusions as treatment for dermatomyositis.
description
1993 nî lūn-bûn
@nan
1993 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1993 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
1993年の論文
@ja
1993年論文
@yue
1993年論文
@zh-hant
1993年論文
@zh-hk
1993年論文
@zh-mo
1993年論文
@zh-tw
1993年论文
@wuu
name
A controlled trial of high-dos ...... treatment for dermatomyositis.
@ast
A controlled trial of high-dos ...... treatment for dermatomyositis.
@en
A controlled trial of high-dos ...... treatment for dermatomyositis.
@nl
type
label
A controlled trial of high-dos ...... treatment for dermatomyositis.
@ast
A controlled trial of high-dos ...... treatment for dermatomyositis.
@en
A controlled trial of high-dos ...... treatment for dermatomyositis.
@nl
prefLabel
A controlled trial of high-dos ...... treatment for dermatomyositis.
@ast
A controlled trial of high-dos ...... treatment for dermatomyositis.
@en
A controlled trial of high-dos ...... treatment for dermatomyositis.
@nl
P2093
P1476
A controlled trial of high-dos ...... treatment for dermatomyositis.
@en
P2093
Dalakas MC
Dambrosia JM
Dinsmore ST
McCrosky S
Soueidan SA
P304
P356
10.1056/NEJM199312303292704
P407
P577
1993-12-01T00:00:00Z